Ohr Pharmaceutical's treatment for an eye condition that can lead to blindness failed to meet a key goal in a mid-stage study, sending shares down 44 percent before the opening bell Friday.

Topics:  ohr pharmaceutical   eye   meet   goal   study sending shares   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News